DHRStock
Verdicts genuinely change. Free email alert the moment DHR's does — no target price to set, unlike a price alert.
Stable Ratio screen, 7 of 7 decided standards passing. No standard's deciding ratio sits within 3 points of its line. What would change it
Whether this company clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Trade setup
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
Trade plan
Posted with a stop, a target and the level that invalidates it. It resolves into the public record either way.
Why this signal?
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
DHR is currently considered halal (Sharia-compliant), per our in-house ratio engine. See the full ratio breakdown and business-activity screen below for the reasoning.
This sits among 434 compliant Healthcare stocks we track. See compliant Healthcare stocks →
How the status reached this point
Compliant · status tracked since Nov 17, 2026
No change to DHR’s published status has been recorded since our daily status check began on Nov 17, 2026. What it read before then is not on record here.
Read once a day from our own screen, last on Nov 17, 2026. The per-methodology record is under “What changed, and when” in the in-house research.
🕌 In-house Compliance Research
Computed from published company financials, balance sheet as of 2026-09-25. These ratios come from the issuer's own published statements rather than structured SEC data.
AAOIFI divides by the market cap: $161.7B as of 2026-11-17. At the 2026-11-18 close it is about $160.4B (the stored market cap moved by the share price since, not a new share count), and at that cap AAOIFI's interest-bearing debt ratio would read 16.5% (16.4% at the stored cap, against a 30% line) and interest-bearing investments ratio would read 3.5% (3.5% at the stored cap, against a 30% line). The published verdict changes only when the company is re-screened.
Business activity: cleared (no excluded categories detected)
AAOIFI Pass 3 of 3 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 16.37% | 30.00% | Pass(13.6pp buffer) |
| Interest-bearing investments | 3.51% | 30.00% | Pass(26.5pp buffer) |
| Non-permissible income | 0.12% | 5.00% | Pass(4.9pp buffer) |
Usmani Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 28.39% | 33.00% | Pass(4.6pp buffer) |
| Interest-bearing investments | 6.09% | 33.00% | Pass(26.9pp buffer) |
| Non-liquid assets | 89.49% | at least 20.00% | Pass(69.5pp above the floor) |
| Non-permissible income | 0.12% | 5.00% | Pass(4.9pp buffer) |
MSCI Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 28.39% | 33.33% | Pass(4.9pp buffer) |
| Cash + interest-bearing securities | 6.09% | 33.33% | Pass(27.2pp buffer) |
| Accounts receivable | 10.51% | 33.33% | Pass(22.8pp buffer) |
| Non-permissible income | 0.12% | 5.00% | Pass(4.9pp buffer) |
FTSE Pass 4 of 4 ratios pass
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 28.39% | 33.33% | Pass(4.9pp buffer) |
| Cash + interest-bearing securities | 6.09% | 33.33% | Pass(27.2pp buffer) |
| Accounts receivable | 10.51% | 50.00% | Pass(39.5pp buffer) |
| Non-permissible income | 0.12% | 5.00% | Pass(4.9pp buffer) |
Dow Jones Islamic Market Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 17.97% | 33.00% | Pass(15.0pp buffer) |
| Cash + interest-bearing securities | 3.86% | 33.00% | Pass(29.1pp buffer) |
| Accounts receivable | 2.80% | 33.00% | Pass(30.2pp buffer) |
| Non-permissible income | 0.12% | 5.00% | Pass(4.9pp buffer) |
S&P Shariah Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 16.92% | 33.00% | Pass(16.1pp buffer) |
| Cash + interest-bearing securities | 3.63% | 49.00% | Pass(45.4pp buffer) |
| Accounts receivable | 2.64% | 49.00% | Pass(46.4pp buffer) |
| Non-permissible income | 0.12% | 5.00% | Pass(4.9pp buffer) |
MSCI M-Series Pass 4 of 4 ratios pass
Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.
| Ratio | Value | Threshold | Result |
|---|---|---|---|
| Interest-bearing debt | 16.92% | 33.33% | Pass(16.4pp buffer) |
| Cash + interest-bearing securities | 3.63% | 33.33% | Pass(29.7pp buffer) |
| Accounts receivable | 6.27% | 49.00% | Pass(42.7pp buffer) |
| Non-permissible income | 0.12% | 5.00% | Pass(4.9pp buffer) |
Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.
How close is it to flipping?
Every current reading against its own line, closest first. A verdict is only as durable as that distance.
The numbers the ratios are built from
Read from DHR's own filings. Every percentage on this page is one of these lines divided by another, so the inputs are shown rather than asserted.
| Line | Figure | As reported | Read from |
|---|---|---|---|
| RevenueTotal revenue for the period | $24.6B | 2025-12-31 | RevenueFromContractWithCustomerExcludingAssessedTax |
| Interest-bearing debtShort and long-term borrowings | $26.5B | 2026-09-25 | LongTermDebtNoncurrent, DebtCurrent |
| Cash and interest-bearing securitiesCash, equivalents and marketable securities | $5.7B | 2026-09-25 | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents |
| Total assetsBalance sheet total | $93.3B | 2026-09-25 | Assets |
| Market capDenominator for AAOIFI | $161.7B | live quote | price x shares |
| 36-month average market capDenominator for S&P Shariah and MSCI M-Series | $158.1B | 756 trading days | closes x shares |
| 24-month average market capDenominator for Dow Jones Islamic Market | $146.8B | 504 trading days | closes x shares |
| Non-permissible revenueInterest and excluded income | $30.0M | 2025-12-31 | InvestmentIncomeInterest |
Two dates, not one: a balance-sheet line and an income-statement line cover different windows by design, so each figure carries its own.
Sources
Filing information. Balance sheet as of 2026-09-25. Income statement as of 2025-12-31. Screened 2026-11-17.
Filing links appear after the next screen: this row was screened before filing citations were recorded.
-
Total assets$93.3B
Assets· balance sheet as of 2026-09-25 -
Interest-bearing debt$26.5B
LongTermDebtNoncurrent, DebtCurrent· balance sheet as of 2026-09-25 -
Cash and interest-bearing securities$5.7B
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents· balance sheet as of 2026-09-25 -
Receivables$4.1B
AccountsReceivableNetCurrent· balance sheet as of 2026-09-25 -
Revenue$24.6B
RevenueFromContractWithCustomerExcludingAssessedTax· income statement as of 2025-12-31 -
Interest income (non-permissible)$30.0M
InvestmentIncomeInterest· income statement as of 2025-12-31 -
Market cap$161.7BMarket-data quote at screen time, 2026-11-17 · not a filing figure, so no link
What changed, and when
Verdict history for DHR. A verdict that never moved is recorded too, so a quiet history reads as measured rather than missing.
- 2026-09-07 No change recorded No verdict change for DHR has been recorded since tracking began. The scan ledger records that the compliance detectors ran, not which symbols each pass covered.
Tracked since 2026-09-07.
Revenue by business segment
How DHR’s $24.6B of revenue for the fiscal year 2025-01-01 to 2025-12-31 splits across what it sells, as the company tags it in its own 10-K.
| Segment | Share | Revenue |
|---|---|---|
| Recurring | 81.9% | $20.1B |
| Nonrecurring | 18.1% | $4.4B |
These are the company’s own segment names and figures. They do not say whether a line of business is permissible; our business-activity screen does.
Source: 10-K filed 2026-02-24 (accession 0000313616-26-000062), read from its XBRL on SEC EDGAR. Shares are of total revenue; subtotals and overlapping cuts the filing also tags are left out, so the lines add up to the total.
What would change the status
The headline verdict is the majority of the decided ratio standards — 7 pass and 0 fail of 7 — with a business-activity screen and any hold applied on top. Balance sheet as of 2026-09-25; market cap as stored on 2026-11-17.
No standard's deciding ratio sits within 3 points of its line.
The ratios that move with the share price
AAOIFI's debt ratio is $26.5B debt over a market cap of $161.7B (as of 2026-11-17), 16.4% against a 30% line.
At the 2026-11-18 close the market cap is about $160.4B (the stored cap moved by the share price since), so this ratio would read 16.5%; the line is -45% from there. The published status changes only when the company is re-screened.
It would fail if the market cap fell to $88.3B (-45%), about $125.47 a share against $229.91 implied by the screen's own figures.
AAOIFI would then fail; the majority verdict would stay Compliant (6 of 7 decided standards passing).
At the screen's market cap, debt would have to rise by $22.0B to reach the line.
AAOIFI would then fail, and the majority verdict would move from Compliant to Not compliant (2 of 7 decided standards passing, counting every standard that divides the same figure).
AAOIFI's investments ratio (3.5% against a 30% line) would only fail if the market cap fell by 88%, to $18.9B. At the 2026-11-18 close it would read 3.5%.
Only AAOIFI divides by the market cap itself. The Dow Jones, S&P and MSCI M-Series standards divide by a 24- or 36-month average and the others by total assets, so a day's price move does not reach them. Figures are the screen's own; the live market cap differs from the stored one.
Shariah-compliant alternatives
Compliant companies in Diagnostics & Research listed on the same market, largest first. Each is screened on its own; none carries a documented concern or a hold.
| Company | Market cap | Price, day |
|---|---|---|
| NTRANatera Inc | $47.2B | — |
| IDXXIdexx Laboratories, Inc. | $44.1B | — |
| AAgilent Technologies Inc. | $43.3B | — |
| WATWaters Corp. | $37.3B | — |
| ILMNIllumina Inc | $33.7B | — |
A dash means no fresh quote is cached for that symbol; this list does not fetch one.
Funds that hold DHR
33 of the 223 funds whose filed holdings we currently hold own DHR shares. That set is a fixed list of widely held index funds and Shariah funds, plus the funds our look-through has read most recently. It is not every fund that owns DHR.
Shariah funds| Fund | DHR in fund | Fund compliant by weight |
|---|---|---|
| MNZL Manzil Russell Halal USA Broad Market ETF | 0.44% | 88% |
| SPUS SP Funds S&P 500 Sharia Industry Exclusions ETF | 0.36% | 79% |
| HLAL Wahed FTSE USA Shariah ETF | 0.34% | 72% |
Widely held U.S. index funds. If you own one, you own DHR through it. None of them is a Shariah fund; the last column is our look-through of each.
| Fund | DHR in fund | Fund compliant by weight |
|---|---|---|
| RSP Invesco S&P 500 Equal Weight ETF | 0.21% | 44% |
| SPY | 0.19% | 56% |
| VOO VANGUARD 500 INDEX FUND | 0.19% | 56% |
| SPYM State Street(R) SPDR(R) Portfolio S&P 500(R) ETF | 0.19% | 56% |
| IVV iShares Core S&P 500 ETF | 0.19% | 56% |
| SCHB Schwab U.S. Broad Market ETF | 0.18% | 53% |
| VTI VANGUARD TOTAL STOCK MARKET INDEX FUND | 0.17% | 54% |
| ITOT iShares Core S&P Total U.S. Stock Market ETF | 0.16% | 54% |
| Fund | DHR in fund | Fund compliant by weight |
|---|---|---|
| LIMAX Cromwell Tran Focus Fund | 5.55% | 66% |
| TCAL T. Rowe Price Capital Appreciation Premium Income ETF | 2.02% | 52% |
| PFM Invesco Dividend AchieversTM ETF | 0.50% | 55% |
| LVPSX LARGE-CAP VALUE PROFUND | 0.41% | 50% |
| CHRI Global X S&P 500 Christian Values ETF | 0.37% | 55% |
| MODL VictoryShares WestEnd US Sector ETF | 0.36% | 53% |
| SNPTX DWS Equity Sector Strategy Fund | 0.28% | 52% |
| PGBHX Blue Chip Fund | 0.25% | 36% |
| CVLC Calvert US Large-Cap Core Responsible Index ETF | 0.22% | 56% |
| AAEQ Alpha Architect US Equity 2 ETF | 0.21% | 57% |
12 more funds
| Fund | DHR in fund | Fund compliant by weight |
|---|---|---|
| JPUS JPMorgan Diversified Return U.S. Equity ETF | 0.20% | 43% |
| QSPIX AQR Style Premia Alternative Fund | 0.20% | not computed |
| SPYX State Street(R) SPDR(R) S&P(R) 500 Fossil Fuel Reserves Free ETF | 0.19% | 54% |
| TISPX Nuveen S&P 500 Index Fund | 0.19% | 53% |
| FBAKX Fidelity Balanced Fund | 0.19% | not computed |
| PSIFX PGIM Quant Solutions Large-Cap Index Fund | 0.18% | 55% |
| SPGM State Street(R) SPDR(R) Portfolio MSCI Global Stock Market ETF | 0.18% | 53% |
| QDPL Pacer Metaurus US Large Cap Dividend Multiplier 400 ETF | 0.17% | 48% |
| VT VANGUARD TOTAL WORLD STOCK INDEX FUND | 0.11% | 50% |
| IIFSX Voya Balanced Income Portfolio | 0.09% | not computed |
| XCHG AB US Equity ETF | 0.07% | 50% |
| FGCKX Fidelity Growth Company Fund | 0.04% | 56% |
Sorted by DHR’s share of each fund, from the fund’s latest SEC N-PORT filing. “Compliant by weight” is the share of the fund’s holdings our look-through screens compliant. A fund is listed only where its filing is mostly equity and names DHR once, so a bond is not counted as the shares; 3 more funds name DHR in a way we cannot separate from its bonds, and are not listed. Shariah funds are those with a recorded certification, on our halal ETF list, or named Shariah, Islamic, Halal or Sukuk.
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| Dodge & Cox | Dodge & Cox | $2,233M | 1.2% | 2026-09-30 |
| Al Gore | Generation Investment Management | $1,129M | 12.0% | 2026-09-30 |
| Stephen Mandel | Lone Pine Capital | $1,095M | 7.1% | 2026-09-30 |
| Ken Fisher | Fisher Asset Management | $1,013M | 0.3% | 2026-09-30 |
| Dan Sundheim | D1 Capital Partners | $668M | 2.1% | 2026-09-30 |
| Lee Ainslie | Maverick Capital | $490M | 3.8% | 2026-09-30 |
| Ken Griffin | Citadel Advisors | $340M | 0.0% | 2026-09-30 |
| Israel Englander | Millennium Management | $313M | 0.1% | 2026-09-30 |
| Chase Coleman | Tiger Global Management | $281M | 1.4% | 2026-09-30 |
| Larry Robbins | Glenview Capital Management | $234M | 3.8% | 2026-09-30 |
| Andreas Halvorsen | Viking Global Investors | $231M | 0.7% | 2026-09-30 |
| First Pacific Advisors | First Pacific Advisors | $124M | 1.5% | 2026-09-30 |
| Paul Tudor Jones | Tudor Investment Corp | $109M | 0.1% | 2026-09-30 |
| David Shaw | D. E. Shaw & Co. | $102M | 0.0% | 2026-09-30 |
| Wally Weitz | Weitz Investment Management | $102M | 7.0% | 2026-09-30 |
| Ray Dalio | Bridgewater Associates | $88M | 0.4% | 2026-09-30 |
| Bill Gates | Gates Foundation Trust | $83M | 0.3% | 2026-09-30 |
| Joel Greenblatt | Gotham Asset Management | $42M | 0.1% | 2026-09-30 |
| Louis Bacon | Moore Capital Management | $8M | 0.2% | 2026-09-30 |
| Azzad Asset Management | Azzad Asset Management | $6M | 0.5% | 2026-09-30 |
| Wahed Invest | Wahed Invest LLC | $3M | 0.3% | 2026-06-30 |
| Caxton Associates | Caxton Associates LLP | $3M | 0.1% | 2026-09-30 |
| Steven Cohen | Point72 Asset Management | $2M | 0.0% | 2026-09-30 |
| Saturna Capital | Amana Mutual Funds Trust | $2M | 0.0% | 2026-09-30 |
| Sallie Krawcheck | Ellevest | $1M | 0.1% | 2026-09-30 |
| Torray Investment Partners | Torray Investment Partners | $0M | 0.1% | 2026-09-30 |
| Bill Nygren | Harris Associates (Oakmark) | $0M | 0.0% | 2026-09-30 |
| David Katz | Matrix Asset Advisors | $0M | 0.0% | 2026-09-30 |
| Mairs & Power | Mairs & Power | $0M | 0.0% | 2026-09-30 |
| Mario Gabelli | GAMCO Investors | $0M | 0.0% | 2026-09-30 |
| Baillie Gifford | Baillie Gifford & Co | $0M | 0.0% | 2026-09-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
Price Forecast
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Technical Summary
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Every indicator, and what it reads
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 46.60 | NEUTRAL |
| Stochastic %K (14) | 20.00 | BUY |
| CCI (20) | -142.74 | BUY |
| Williams %R (14) | -80.00 | BUY |
| MACD (12,26,9) | -1.31 | SELL |
| ROC (10) | -3.78 | SELL |
| Momentum (10) | -8.87 | SELL |
| EMA (10) | 230.12 | SELL |
| SMA (10) | 231.01 | SELL |
| EMA (20) | 229.83 | SELL |
| SMA (20) | 231.58 | SELL |
| EMA (30) | 228.18 | SELL |
| SMA (30) | 229.35 | SELL |
| EMA (50) | 224.03 | BUY |
| SMA (50) | 223.68 | BUY |
| EMA (100) | 215.96 | BUY |
| SMA (100) | 212.69 | BUY |
| EMA (200) | 210.94 | BUY |
| SMA (200) | 200.56 | BUY |
About DHR
Healthcare · Diagnostics & Research
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, and aseptic fill finish; single-use hardware, consumables, and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services for diagnostic and assay development; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; bioanalytical measurement systems; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; genome sample preparation; microscopes; protein consumables; filtration products; and genomic medicines, such as custom nucleic acid products, and plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, GENEDATA, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX, and SCIEX brands. The Diagnostics segment offers clinical instruments, consumables, software, and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was incorporated in 1969 and is headquartered in Washington, the District Of Columbia.
Background via Yahoo Finance — informational, not part of the verdict.
Latest Signal — 2026-11-17
Stop 223.29 Now 225.70 Target 233.30
⚪ NEUTRAL — No Edge
Signals are mixed with no clear edge in either direction. Stand aside and wait for one more confluence factor.
Scores: 2 bullish / 2 bearish
Average — needs more confirmation before sizing up
SMC — Top Down
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | RANGING | 64 |
| ⏰ 4H | BEARISH | 40 |
| 🕐 1H | BEARISH | 98 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Momentum & Volume
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
Peer Movement
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
Before you act on this
The questions worth asking about any verdict on this page, answered plainly.
Is this a fatwa?
No. HTR applies published screening standards to a company's own filings and shows the result under each one. It is research, not a religious ruling. For a ruling that applies to you, ask a qualified scholar.
Why can the standards disagree?
Because they measure different things. Some divide interest-bearing debt by market cap, others by total assets, and the thresholds differ too. The same filing can clear one line and cross another. HTR shows every verdict rather than averaging them into one label.
How often is this re-screened?
Ratios are recomputed when a new filing lands, and the whole watchlist is re-screened on a rolling basis. The date on the verdict above is the last time this symbol was actually recomputed, not the last time the page was built.
Do I need to purify dividends?
If a company earns some non-permissible income, many scholars hold that the same share of any dividend should be given away. The non-permissible income figure above is the number that calculation starts from — the purification calculator finishes it, showing the filing figures behind the ratio and both the proportional and the AAOIFI per-share convention.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Compare with
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Insider Activity (90d)
Insider transactions reported in the last ninety days. Insiders sell for reasons that have nothing to do with a view, so a sale on its own is not a signal.
BEARISH 0 buys · 2 sells
Recent: Blair Rainer sold 46948 sh @ $217.77 (2026-08-21); Blair Rainer sold 7755 sh @ $218.73 (2026-08-21)
COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-11-10 · Asset managers net 914130 (-14454)
AI Summary
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.